Exelixis Inc. diskutieren
Exelixis Inc.
WKN: 936718 / Symbol: EXEL / Name: Exelixis / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
21,53 €
1,61 %
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at TD Cowen from $25.00 to $27.00. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $28.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for EXEL provided by MarketBeat
Exelixis, Inc. (NASDAQ: EXEL) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for EXEL provided by MarketBeat
Neueste Beiträge
StockNews_com in MPLX L.P. diskutieren